PDCD1 and neoplasm: In conclusion, although the treatment with anti-PD-1 antibody reduces tumor growth in mice challenged with melanoma cells, we have found that this treatment induces the expression of PD-L1 and other immunosuppressive mediators via up-regulation of IFNγ.